Tonsillotomy for Periodic Fever Syndrome: A Randomized and Controlled Trial
The Laryngoscope · 2024-02 · 134 (2) · 968-972
DOI: 10.1002/lary.30863 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Laryngoscope, online erschienen am 21.07.2023. Verfasst von Ulla Lantto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medicine Research Unit, Medical Research Center, University of Oulu, Oulu, Finland. Hauptthemen laut MEDLINE: Tonsillectomy, Pharyngitis, Lymphadenitis, Lymphadenopathy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Finnish ORL-HNS Foundation, The Foundation for Paediatric Research, Finland.
Abstract (Originalsprache)
Objective
Tonsillectomy is an effective treatment for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome. Tonsillotomy has a milder operative risk profile and postoperative morbidity in children than tonsillectomy. We aimed to compare the efficacy of tonsillotomy to observation‐only in children with PFAPA syndrome at a 3‐month follow‐up.
Methods
This was a randomized multicenter trial with sequential design. Participants were randomized into a tonsillotomy group and a control group that was only observed. The trial started in 1/2017 and was accomplished in 12/2021 with 16 patients (10 boys, six girls, the mean age 4.2 years). The symptoms were monitored with daily symptom diaries.
Results
After the 3‐month follow‐up, 7/8 patients (87.5%) in the tonsillotomy group and 2/8 (25%) patients in the control group were free from PFAPA symptoms (95% CI 13% to 87%; p = 0.0021). The mean number of days with fever was 2.6 (SD 3.7) in the tonsillotomy group and 8.0 (SD 6.5) days in the control group ( n = 8) ( p = 0.06). Mean number of fever days compatible with PFAPA syndrome was 0.8 (SD 1.4) in the tonsillotomy group and 6.5 (SD 6.0) in the control group (95%CI −10% to −1%; p = 0.007). Rescue tonsillectomy was needed for all patients in the control group and none of the patients in the tonsillotomy group.
Conclusions
Tonsillotomy might be an effective treatment option for children with PFAPA syndrome. Further studies are needed to clarify the long‐term efficacy of tonsillotomy for treating PFAPA. Level of Evidence 2 Laryngoscope , 134:968–972, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Medicine Research Unit, Medical Research Center, University of Oulu, Oulu, Finland.
- Department of Otorhinolaryngology-Head and Neck Surgery, Oulu University Hospital, Oulu, Finland.
- Department of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland.
- Tampere Center for Child, Adolescent and Maternal Health Research, Tampere, Finland.
- Department of Otorhinolaryngology-Head and Neck Surgery, Turku University Hospital, Turku, Finland.
- Department of Otorhinolaryngology, Faculty of Medicine, University of Turku, Turku, Finland.
ORCID-Profile: Ulla Lantto
Förderung
- The Finnish ORL-HNS Foundation
- The Foundation for Paediatric Research, Finland
Zitieren
APA
Lantto, U., Tapiainen, T., Pokka, T., Koivunen, P., Helminen, M., Piitulainen, J., Rekola, J., Uhari, M., & Renko, M. (2024). Tonsillotomy for Periodic Fever Syndrome: A Randomized and Controlled Trial. The Laryngoscope, 134(2), 968-972. https://doi.org/10.1002/lary.30863
Vancouver
Lantto U, Tapiainen T, Pokka T, Koivunen P, Helminen M, Piitulainen J, et al. Tonsillotomy for Periodic Fever Syndrome: A Randomized and Controlled Trial. The Laryngoscope. 2024;134(2):968-972. doi:10.1002/lary.30863
BibTeX
@article{Lantto2024,
author = {Lantto, Ulla and Tapiainen, Terhi and Pokka, Tytti and Koivunen, Petri and Helminen, Merja and Piitulainen, Jaakko and Rekola, Jami and Uhari, Matti and Renko, Marjo},
title = {Tonsillotomy for Periodic Fever Syndrome: A Randomized and Controlled Trial},
journal = {The Laryngoscope},
year = {2024},
volume = {134},
number = {2},
pages = {968--972},
doi = {10.1002/lary.30863}
}
EUVIMED